ArticleCancer medicine2026

Construction and Validation of a Progression-Free Survival Prediction Model for Newly Diagnosed Multiple Myeloma Patients With 1q21 Gain/Amplification.

Yuexuan Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.